retatrutide weight loss retatrutide clinical trial The trillion-dollar peptide. Appearing on @tbpn, Andrew Huberman said could be the peptide that “changes everything.” Now in Phase III trials, it's shown up to 30% body in Medscape | Retatrutide, Eli Lilly's

To view or add a comment, sign in Diabetic neuropathy is a leading cause of foot complications, including ulcers and amputations, yet early detection and new interventions can make all the difference

Similarly, a 2021 review of phase III clinical trials concluded that GLP-1 medications reduce A1c

As of the time of writing, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) and it remains under clinical investigation

Call NHS 111 for urgent advice if your GP or clinical trial team is unavailable and you are concerned about symptoms that are not immediately life-threatening